v3.26.3
Molecule.ai Asset Acquisition (Tables)
 6 Months Ended
Jun. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Total Purchase Consideration

The total acquisition date purchase consideration as determined by the Company is as follows:

  

Consideration *  Dollar Value 
Closing Cash  $3,000,000 
Accelerated portion of the First Installment   564,073 
Six Month Installment   2,435,927 
Twelve Month Installment   2,000,000 
Technology Development Milestone 1**   1,000,000 
Technology Development Milestone 2**   1,000,000 
Total purchase consideration  $10,000,000 

 

*The purchase consideration table above reflects the acquisition-date terms of the Molecule.ai APA. As discussed above, the parties entered into a Second Amendment on May 4, 2026, which modified the remaining payment obligations and was accounted for as a separate debt extinguishment transaction.
**These payments were contingent upon the achievement of certain milestones. During the six months ended June 30, 2026, the Technology Development Milestone 1 and 2 were achieved. As a result, the Company remitted $1.75 million of the contingent milestone payments and has $0.25 million due to the Selling Party, which is included in contingent consideration liability on the consolidated balance sheets.
Schedule of Carrying Value of Development Technology Asset

The carrying value of the developed technology asset is summarized as follows:

  

      
Carrying value as of December 31, 2024  $— 
      
Developed technology acquired   10,117,304 
Amortization expense   (288,062)
Software in progress   12,000 
Carrying value as of December 31, 2025  $9,841,242 
Amortization expense   (1,264,663)
Software in progress   72,000 
Carrying value as of June 30, 2026  $8,648,579